The objective of the proposed project is to further develop medication delivery system of SAVIOR™ medical device into a prototype model ready for testing, from TR3 to TRL6. The next step of developmen...
MACH32 INC.
11 records totalling $436,733.75 CAD, from official Government of Canada open data.
Embed this chart
By department
| National Research Council Canada | $436,734 | 11 records |
Records
This project aims to develop a smaller, intramuscular autoinjector capable of delivering a concentrated formulation of tranexamic acid (TXA), a widely used antifibrinolytic for treating hemorrhage. Th...
MACH32 plans to complete a market assessment for the top 2 IMSAFE markets, military, first responder. This assessment will include information on pricing, volumes, use cases, reimbursement, and channe...
The objective of the proposed project is to improve the first prototype of the Aerosol Containment (ACT) medical device by collecting user feedback, conducting additional product testing and clinical...
MACH32 is developing a drug-device combination medical product for early intervention and treatment of severe hemorrhage. This device administers a large-volume dose of the antifibrinolytic drug tra...
COVID-19 can be spread in an airborne manner through aerosolized droplets during medical procedures. Due to this concern many lifesaving interventions are not being used during the COVID-19 pandemic....
MACH32 is currently developing a novel medical device for use in trauma treatment and is is called SAVIOR™. In simple terms, SAVIOR™ Is a fail-proof, simple to use auto injector analogous to the “Epip...
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
The funding provided from the IAP program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Rese...